Search

everythinglearnresearchcommunity

for

Search:↓

A genetic marker linked to a type of hair loss was found in most patients studied.

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

The growth factor cocktail with FGF9 significantly increased hair density and diameter in patients with androgenetic alopecia.

Glypicans help hair follicle stem cells differentiate by interacting with specific receptors, influencing hair growth.

HFMs can help study hair growth and test potential hair growth drugs.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

FGF13 gene changes cause excessive hair growth in a rare condition.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

High-frequency ultrasound effectively evaluates and diagnoses frontal fibrosing alopecia.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

IFHUT shows better hair growth than FUE, but needs improvements in positioning, speed, and accuracy.

Hair testing can detect a single GHB exposure, useful for documenting sexual assault.

HASHA is a safe and effective option for chin augmentation.

5-α-reductase inhibitors, intralesional steroids, and hydroxychloroquine are the most effective treatments for frontal fibrosing alopecia.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

The HFE hair transplant method is effective, safe, and provides natural-looking results with quick recovery for men with hair loss.

A new hair restoration technology was found to effectively increase hair thickness, density, and growth, while reducing hair loss and improving scalp health, with no side effects.

CGF injections may safely and effectively promote hair growth in androgenetic alopecia patients.

Growth hormone-releasing hormone (GHRH) boosts hair growth and human scalp hair follicles have their own growth hormone system.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

The document concludes that AFA should be considered in patients with acromegaly-like features but normal hormone levels, and more cases need to be identified to understand the condition fully.

Iontophoresis with a growth factor cocktail helps hair growth in patients with androgenetic alopecia.

Frontal fibrosing alopecia can be diagnosed by examining facial areas and treated with specific medications to stop its progression.

HGF-modified hair follicle stem cells help brain recovery after injury in rats.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.

Different forms of FGF5 either promote or inhibit hair growth.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The treatment increased hair growth and thickness in patients with hair loss.